Loading summary
Mint Mobile Ad
This message comes from Mint Mobile. From the gas pump to the grocery store, inflation is everywhere. So Mint Mobile is offering premium wireless starting at just $15 a month. To get your new phone plan for just $15, go to mintmobile.com switch live.
Jeanine Herbst
From NPR News in Washington, I'm Jeanine Herbst. The Israeli government today approved a plan to expand settlements on the occupied Golan Heights. Prime Minister Benjamin Netanyahu said in a statement that strengthening the Golan Heights means strength, strengthening Israel, and is especially important at this time. Since the Assad regime was toppled in Syria, Israel has launched hundreds of airstrikes across that country and carried out incursions past the Golan Heights to the previously demilitarized zone. Meanwhile, Israel has closed its embassy in Dublin over what it calls the anti Israel policy of the Irish government as relations deteriorate over the war in Gaza. And the Israeli military has started withdrawing from parts of southern Lebanon as part of a ceasefire agreement with Hezbollah. It's supposed to end the deadly conflict, which started last October between the 2. But as NPR's Emily Fang reports, Israeli strikes continue to hit Lebanon.
Emily Fang
Israel's military said in a statement that it had destroyed some 300 sites in the past week belonging to Hezbollah, the paramilitary organization that is influential in Lebanon. It also said it had, quote, eliminated many terrorists in operations, especially around a Lebanese town called Heam. Heam is also where the Lebanese military started redeploying this past week as part of the ceasefire agreement signed in late November. Leban, Lebanon's defense minister, accused Israel of violating the ceasefire. And the Lebanese health ministry said one person had been killed by an Israeli drone in Chiam the day after the Lebanese army moved in. Emily Fang, NPR News, Beirut, Lebanon.
Jeanine Herbst
President elect Donald Trump's pick to head the Department of Health and Human Services, Robert F. Kennedy, Jr. Is due on Capitol Hill this week to meet with senators. Kennedy, as an independent presidential candidate this year, ran on an anti vaccine campaign and his personal lawyer had reportedly filed suit to get the FDA to ruin revoke the polio vaccine that has gotten pushback from Republican Senator Mitch McConnell, a polio survivor. And Piers Franco Ordonez has more.
Piers Franco Ordonez
Now, Kennedy himself says he doesn't want to take away anyone's choice to take vaccines. But still, McConnell, without naming Kennedy, said any efforts to undermine public confidence in proven cures are, quote, not just uninformed, they're dangerous. He went on to say that anyone seeking Senate confirmation would, quote, do well to steer clear of even the appearance of association with such efforts.
Jeanine Herbst
NPR's Franco Ordonez unidentified drones over the Northeast have led to a lot of speculation and concern, and now Germany says there have been sightings over sensitive military and industrial sites, including a U.S. air Force base. NPR's Rob Schmitz has more.
Rob Schmitz
The sightings, first reported by Der Spiegel magazine, were made by German security authorities who reported several drones flying over the Ramstein US Air Force Base on December 3rd and 4th. The report also said unidentified drones were seen over facilities belonging to arms maker Rheinmetall. A spokesperson for the U.S. air Force says its Ramstein base is unaffected.
Jeanine Herbst
NPR's Rob Schmitz. This is NPR News. Humira is one of the biggest blockbuster drugs of the last two decades. It treats things like psoriasis, certain kinds of arthritis and Crohn's disease. NPR Sidney Lupkin reports on a new study that looks at whether patients are switching to lower cost alternatives for complex drugs like Humira.
Sidney Lupkin
The copies aren't identical like they are for typical generic drugs, but the alternatives are close and they're called biosimilars. In the first year of biosimilar competition for Humira, however, the alternatives didn't win much of the market. Ben Rohm of Harvard Medical School co authored a new study published in the journal JAMA Health forum, finding only 2% of prescriptions were for the biosimilars. When the biosimilars have such difficulty getting traction, what it means is that the next time a big blockbuster drug faces competition, maybe biosimilar makers are less excited to come to market. He says health insurers paid less for Humira even as its manufacturer raised its official list price. Sidney Lupkin, NPR News.
Jeanine Herbst
In the French territory of Mayotte, the official death toll from Cyclone Chito is at least 11 people, with hundreds injured, according to the island's top government official. But he says it's extremely difficult to get an exact number right now. After the Indian Ocean's island were pummeled pummeled rather, by the intense cyclone yesterday, officials say that death toll could rise to the hundreds. France rushed rescue teams and supplies to its largely poor overseas department in the Indian Ocean that suffered widespread destruction, including at the airport and flattening of neighborhoods. Power is also out in many areas. You're listening to NPR News from Washington.
Mint Mobile Ad
This message comes from Bombas. Socks, underwear and T shirts are the top three requested clothing items by people experiencing homelessness. Bombas makes all 3 and donates one item for every item purchased. Go to bombas.com NPR and use code NPR for 20% off.
NPR News Now: December 15, 2024, 6PM EST Summary
NPR News Now delivered a comprehensive update on major global and domestic events in its December 15, 2024, 6PM EST episode. Covering topics ranging from Middle Eastern geopolitics and US political developments to international security concerns, healthcare industry updates, and natural disaster impacts, the episode provided listeners with concise yet detailed insights. Below is a structured summary capturing the key discussions, notable quotes, and essential conclusions from the broadcast.
Israeli Settlement Expansion in the Golan Heights
The episode opened with significant news from the Middle East. Jeanine Herbst reported that the Israeli government approved a plan to expand settlements in the occupied Golan Heights. Prime Minister Benjamin Netanyahu emphasized the strategic importance of this move, stating:
"Strengthening the Golan Heights means strength, strengthening Israel, and is especially important at this time."
— Jeanine Herbst [00:17]
This decision comes amid heightened tensions following the toppling of the Assad regime in Syria. Israel has conducted numerous airstrikes and incursions into Syria beyond the Golan Heights, challenging the region's previously demilitarized status.
Deteriorating Israel-Ireland Relations and Ceasefire with Hezbollah
Further complicating the geopolitical landscape, Israel has closed its embassy in Dublin, citing the Irish government's anti-Israel policies, particularly concerning the ongoing war in Gaza. Concurrently, despite a ceasefire agreement signed in late November with Hezbollah, Israeli military operations continue in southern Lebanon. Emily Fang provided detailed insights:
"Lebanon's defense minister accused Israel of violating the ceasefire, and the Lebanese health ministry reported that one person was killed by an Israeli drone in Chiam the day after the Lebanese army redeployed."
— Emily Fang [01:11]
Fang highlighted that the Israeli military claimed to have destroyed approximately 300 Hezbollah sites in the past week, particularly around the Lebanese town of Heam. However, the Lebanese authorities remain skeptical of Israel's adherence to the ceasefire, indicating ongoing instability in the region.
Nomination of Robert F. Kennedy Jr. for HHS
Jeanine Herbst shifted focus to US politics, announcing that President-elect Donald Trump’s nominee for the Department of Health and Human Services (HHS) is Robert F. Kennedy Jr. Kennedy's controversial stance on vaccines has sparked significant debate. As an independent presidential candidate, his anti-vaccine campaign has drawn criticism, particularly from Republican Senator Mitch McConnell.
Senator McConnell's Opposition to Kennedy's Appointment
Piers Franco Ordonez elaborated on the political tension surrounding Kennedy's nomination:
"McConnell, without naming Kennedy, said any efforts to undermine public confidence in proven cures are, 'not just uninformed, they're dangerous.' He went on to say that anyone seeking Senate confirmation would, 'do well to steer clear of even the appearance of association with such efforts.'"
— Piers Franco Ordonez [02:15]
Kennedy has maintained that he does not intend to remove individuals' choices regarding vaccines. However, McConnell's strong opposition underscores the potential hurdles Kennedy may face in securing Senate approval for his appointment.
Unidentified Drone Sightings Over US and German Military Sites
Rob Schmitz reported escalating security concerns involving unidentified drones:
"Sightings were first reported by Der Spiegel magazine, detailing several drones flying over the Ramstein US Air Force Base on December 3rd and 4th, as well as over facilities belonging to arms maker Rheinmetall. The US Air Force has stated that Ramstein base remains unaffected."
— Rob Schmitz [02:51]
These incidents have heightened alarms over potential threats to sensitive military and industrial sites. The drones' origins and intentions remain unclear, prompting increased vigilance among security authorities in both Germany and the United States.
Humira's Market Position and the Challenge of Biosimilars
Sidney Lupkin discussed the pharmaceutical landscape, focusing on Humira, a leading drug for conditions like psoriasis, arthritis, and Crohn's disease. Despite the introduction of biosimilars—drugs similar to biologics but not identical—the adoption rate remains low.
"In the first year of biosimilar competition for Humira, only 2% of prescriptions were for the biosimilars. This limited uptake suggests that future biosimilar makers might be less motivated to enter the market when facing competition from blockbuster drugs that retain strong market presence despite higher costs."
— Sidney Lupkin [03:36]
Ben Rohm of Harvard Medical School, a co-author of the related study published in the JAMA Health Forum, emphasized the implications for the healthcare market:
"Health insurers paid less for Humira even as its manufacturer raised its official list price, indicating that cost pressures do not necessarily drive patients toward more affordable alternatives."
— Ben Rohm (via Sidney Lupkin) [03:36]
This scenario raises concerns about the sustainability of biosimilar markets and the broader impact on drug pricing and accessibility.
Cyclone Chito Devastates Mayotte
The episode also covered the severe impact of Cyclone Chito on Mayotte, a French overseas territory in the Indian Ocean. Jeanine Herbst relayed distressing updates:
"The official death toll from Cyclone Chito stands at least 11, with hundreds injured. However, officials caution that the numbers could rise to the hundreds as rescue operations continue amidst widespread destruction, including the airport and residential neighborhoods. Power outages are affecting many areas, prompting France to dispatch rescue teams and essential supplies to aid the affected populations."
— Jeanine Herbst [04:17]
The cyclone’s intensity has wrought significant damage on an already vulnerable region, highlighting the challenges of disaster response in economically disadvantaged areas.
The December 15, 2024, episode of NPR News Now provided a multifaceted overview of pressing issues across the globe and within the United States. From geopolitical tensions in the Middle East and political maneuverings in the US to security threats posed by unidentified drones, advancements and challenges in the healthcare sector, and the devastating effects of natural disasters, the program offered listeners a thorough briefing on current events shaping the world.
Note: This summary omits advertisements, intros, outros, and non-content segments to focus solely on the informative aspects of the episode.